Aberdeen Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Aberdeen Wealth Management's MDT Position: Q2 2026 in Review
Aberdeen Wealth Management reduced its Medtronic (MDT) stake by 45% in Q2 2026, selling an estimated $431K and leaving 6,508 shares worth $509K. The position accounts for 0.24% of the portfolio, ranked #66.
Aberdeen Wealth Management first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.64M in Q2 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Aberdeen Wealth Management held 6,508 shares of Medtronic worth $509K as of Q2 2026.
- Aberdeen Wealth Management sold 5,346 Medtronic shares in Q2 2026, an estimated $431K.
- Medtronic made up 0.24% of Aberdeen Wealth Management's portfolio in Q2 2026, its #66 holding.
- Aberdeen Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
- Aberdeen Wealth Management's Medtronic position peaked at $1.64M in Q2 2021.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.